• NVP015 Program Accelerated Through Research Grant to CHOP americanpharmaceuticalreview
    August 29, 2018
    NeuroVive Pharmaceutical announced scientists at the company's research partner the Children's Hospital of Philadelphia (CHOP) have received a three-year grant (W81XWH-17-PRMRP-TTDA), in total of $4,090,281 USD, from the U.S. Department of Defense, Office
PharmaSources Customer Service